Search results
Showing 1426 to 1440 of 2188 results for guidelines
NICE has developed a Medtech Innovation Briefing (MIB) on Oxyzyme and Iodozyme 2-layer hydrogel wound dressings with iodine for treating chronic wounds
catheters, but are also more expensive. The clinical evidence review for the guideline revealed an absence of evidence for the...
Any explanatory notes(if applicable) Why this is important:- The Guideline Development Group's (GDG's) recommendation to consider...
Evidence summaries: new medicines – Interim process statement (PMG1)
This interim process statement sets out to guide the development of 'Evidence summaries: new medicines' (ESNMs). It provides an overview of the key process principles and describes all stages of the development of ESNMs
Omalizumab for previously treated chronic spontaneous urticaria (TA339)
Evidence-based recommendations on omalizumab (Xolair) for treating severe chronic spontaneous urticaria in people of 12 and over.
Pulmonary artery pressure technologies for remote monitoring of chronic heart failure (HTG769)
Evidence-based recommendation on the routine use of pulmonary artery pressure technologies for remote monitoring of chronic heart failure.
after an acute stroke are at higher risk of aspiration pneumonia. The guideline development group considered how best to reduce the...
treatment at a variety of time points. A meta-regression undertaken by the Guideline Development Group suggested that very early (before...
the studies were limited in number and generally of low quality. The guideline committee agreed that further research in this area...
unreasonable clinical expectation. The economic model presented in this guideline suggested that radiofrequency denervation is likely to...
HTG EdgeSeq ALKPlus Assay EU for ALK status testing in non-small-cell lung cancer (MIB128)
NICE has developed a medtech innovation briefing (MIB) on HTG EdgeSeq ALKPlus Assay EU for ALK status testing in non-small-cell lung cancer .
Remote ECG interpretation consultancy services for cardiovascular disease (MIB152)
NICE has developed a medtech innovation briefing (MIB) on remote ECG interpretation consultancy services for cardiovascular disease .
Bimekizumab for treating moderate to severe plaque psoriasis (TA723)
Evidence-based recommendations on bimekizumab (Bimzelx) for treating moderate to severe plaque psoriasis in adults.
Dapagliflozin in triple therapy for treating type 2 diabetes (TA418)
Evidence-based recommendations on dapagliflozin (Forxiga) given with 2 other drugs for treating type 2 diabetes in adults.
develop future guidance (the recommendation on this topic in the current guideline was based on GDG consensus). A randomised controlled...